Brain Tumors and Beyond: Multi-Compartment Microbiome and Mycobiome Analysis
Open Access
- 24 January 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (3) , 991
Abstract
Brain tumors are frequently diagnosed diseases in which etiology and progression largely depend on mutations and genetic factors. Additionally, recent reports document that the microbiome may influence tumor growth, tumor microenvironment, and response to therapy. Our goal was to examine the extent to which the bacterial composition—microbiota—and fungal composition—mycobiota—characteristic of the tumor and its microenvironment correlate with the composition of the gut and blood microbiota and mycobiota in five randomly selected brain tumor patients. The bacterial composition of the tumor, tumor-adjacent tissue (TAT), blood, and gut samples of the five patients were analyzed by 16S rRNA and ITS-based sequencing in order to determine the bacterial and fungal composition. The gut microbiome and mycobiome composition showed individual and tissue-specific signatures in each patient. The microbiome composition of the blood, TAT, and tumor tissue was very similar in each patient, dominated by Klebsiella, Enterococcus, Blautia, and Lactobacillus spp. In contrast, the mycobiome composition of the blood, TAT, and tumor showed a diverse, individual picture. The most common fungal species in the blood and TAT were Tomentella, Didymosphaeria, Alternaria, Penicillium, Mycosphaerella, and Discosia. The blood and TAT mycobiome were similar to each other but unique and characteristic of the patients. In contrast, in the tumor tissues, Alternaria, Malassezia, Schizophyllum, and Tomentella genus were the most common fungi genus. Our results showed that the presence of fungi in tumors shows a unique pattern that is independent of the pattern observed in the gut, blood, and tumor environment and that the effects of the mycobiome are distinct and cannot be associated with those of the microbiome. Elucidating the role of fungi in tumors and exploring the relationship between fungi and brain tumor types may open up further therapeutic options.Keywords
Funding Information
- HUN-REN-SU, Human Microbiota Study Group (0272)
This publication has 51 references indexed in Scilit:
- The gut-brain-axis: A positive relationship between gut microbial dysbiosis and glioblastoma brain tumourHeliyon, 2024
- A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumorsCell, 2022
- Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactionsCell, 2022
- Microbiota and the gut-brain-axis: Implications for new therapeutic design in the CNSEBioMedicine, 2022
- Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancerCancer Cell, 2022
- Updates on Surgical Management and Advances for Brain TumorsCurrent Oncology Reports, 2021
- Role of Non-Albicans Candida and Candida Albicans in Oral Squamous Cell Cancer PatientsJournal of Oral and Maxillofacial Surgery, 2018
- Dysbiosis signature of mycobiota in colon polyp and colorectal cancerEuropean Journal of Clinical Microbiology & Infectious Diseases, 2017
- Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal CarcinogenesisCell Host & Microbe, 2017
- Microbiota as a mediator of cancer progression and therapyTranslational Research, 2017